AEMS Corp.
PrivateLast Round
Debt
Mar 9, 2026
Total Funding Raised
$800,000
Company Overview
AEMS Corp. is a biotechnology company that provides viscosity solutions for pharmaceutical and industrial formulations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AEMS Corp. Comps
Public and private peers based on sector, stage, and business model.
AEMS Corp. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 9, 2026 | ||||
| Debt | May 9, 2025 | ||||
| Seed | May 9, 2025 | ||||
| Grant | May 18, 2023 | ||||
| Pre Seed | Oct 19, 2022 |
Key People
Founding team and executive leadership
AEMS Corp. Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 9, 2026
$100K debt round raised.
AEMS Corp. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AEMS Corp.'s valuation, stock price, and market status.
